Cargando…
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods
BACKGROUND: Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state‐of‐the‐art. AIM: To describe differences of MDTMs by tumour type. METHODS: Twelve multidisciplinary team meetings (MDTMs) with participation of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351662/ https://www.ncbi.nlm.nih.gov/pubmed/34582132 http://dx.doi.org/10.1002/cnr2.1541 |
_version_ | 1784762482482479104 |
---|---|
author | Hitz, Felicitas Ribi, Karin Grote, Gudela Kolbe, Michaela Schmitz, Christof Lamb, Benjamin W. Ruhstaller, Thomas Berchtold, Peter Sevdalis, Nick |
author_facet | Hitz, Felicitas Ribi, Karin Grote, Gudela Kolbe, Michaela Schmitz, Christof Lamb, Benjamin W. Ruhstaller, Thomas Berchtold, Peter Sevdalis, Nick |
author_sort | Hitz, Felicitas |
collection | PubMed |
description | BACKGROUND: Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state‐of‐the‐art. AIM: To describe differences of MDTMs by tumour type. METHODS: Twelve multidisciplinary team meetings (MDTMs) with participation of different cancer disease specialists at a tertiary hospital were assessed by an exploratory sequential mixed method approach with interviews, observations and a survey to address the following five topics: organisational structure and supporting technology; leadership; teamwork; decision‐making, perceived value and motivation. Thirteen persons with different tumour specialities and levels of seniority were interviewed. The 12 MDTMs were observed twice by uninvolved persons and evaluated by the participating physicians with a survey. RESULTS: There were no systematic differences between MDTMs for different tumour types with the exception of the non‐disease specific type MDTM, which was the only one for which the organisational structure was not driven by an electronic tool. However, several factors could be identified that generally influenced the functioning of the MDTMs. In particular, the quality of decision‐making was highly dependent on the availability of case‐based information and the presence of relevant cancer disease specialists. Leadership and teamwork were rated as important and were comparable across the MDTM. Team participants' motivation and perceived value of MDTMs was high across all meetings. CONCLUSION: MDTM at a single institution did not demonstrate disease specific characteristics. An effective MDTM, irrespective of the tumour type, can be successfully structured by technical means and a chairperson coordinating the interaction of cancer disease specialists to improve the decision‐making process. |
format | Online Article Text |
id | pubmed-9351662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93516622022-08-09 Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods Hitz, Felicitas Ribi, Karin Grote, Gudela Kolbe, Michaela Schmitz, Christof Lamb, Benjamin W. Ruhstaller, Thomas Berchtold, Peter Sevdalis, Nick Cancer Rep (Hoboken) Original Articles BACKGROUND: Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state‐of‐the‐art. AIM: To describe differences of MDTMs by tumour type. METHODS: Twelve multidisciplinary team meetings (MDTMs) with participation of different cancer disease specialists at a tertiary hospital were assessed by an exploratory sequential mixed method approach with interviews, observations and a survey to address the following five topics: organisational structure and supporting technology; leadership; teamwork; decision‐making, perceived value and motivation. Thirteen persons with different tumour specialities and levels of seniority were interviewed. The 12 MDTMs were observed twice by uninvolved persons and evaluated by the participating physicians with a survey. RESULTS: There were no systematic differences between MDTMs for different tumour types with the exception of the non‐disease specific type MDTM, which was the only one for which the organisational structure was not driven by an electronic tool. However, several factors could be identified that generally influenced the functioning of the MDTMs. In particular, the quality of decision‐making was highly dependent on the availability of case‐based information and the presence of relevant cancer disease specialists. Leadership and teamwork were rated as important and were comparable across the MDTM. Team participants' motivation and perceived value of MDTMs was high across all meetings. CONCLUSION: MDTM at a single institution did not demonstrate disease specific characteristics. An effective MDTM, irrespective of the tumour type, can be successfully structured by technical means and a chairperson coordinating the interaction of cancer disease specialists to improve the decision‐making process. John Wiley and Sons Inc. 2021-09-28 /pmc/articles/PMC9351662/ /pubmed/34582132 http://dx.doi.org/10.1002/cnr2.1541 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Hitz, Felicitas Ribi, Karin Grote, Gudela Kolbe, Michaela Schmitz, Christof Lamb, Benjamin W. Ruhstaller, Thomas Berchtold, Peter Sevdalis, Nick Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods |
title | Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods |
title_full | Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods |
title_fullStr | Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods |
title_full_unstemmed | Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods |
title_short | Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods |
title_sort | team functioning across different tumour types: insights from a swiss cancer center using qualitative and quantitative methods |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351662/ https://www.ncbi.nlm.nih.gov/pubmed/34582132 http://dx.doi.org/10.1002/cnr2.1541 |
work_keys_str_mv | AT hitzfelicitas teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT ribikarin teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT grotegudela teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT kolbemichaela teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT schmitzchristof teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT lambbenjaminw teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT ruhstallerthomas teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT berchtoldpeter teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods AT sevdalisnick teamfunctioningacrossdifferenttumourtypesinsightsfromaswisscancercenterusingqualitativeandquantitativemethods |